Voisard Asset Management Group, Inc. Moderna, Inc. Transaction History
Voisard Asset Management Group, Inc.
- $240 Billion
- Q3 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 5 shares of MRNA stock, worth $251. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5Holding current value
$251% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
1,027Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO42.5MShares$2.14 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$1.99 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.29 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$756 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$363 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $19.7B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...